Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR

Rationale: Tezacaftor (formerly VX-661) is an investigational small molecule that improves processing and trafficking of the cystic fibrosis transmembrane conductance regulator (CFTR) in vitro, and improves CFTR function alone and in combination with ivacaftor. Objectives: To evaluate the safety and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Respir Crit Care Med
Päätekijät: Donaldson, Scott H., Pilewski, Joseph M., Griese, Matthias, Cooke, Jon, Viswanathan, Lakshmi, Tullis, Elizabeth, Davies, Jane C., Lekstrom-Himes, Julie A., Wang, Linda T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Thoracic Society 2018
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5768901/
https://ncbi.nlm.nih.gov/pubmed/28930490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201704-0717OC
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia